GH1 and Prader-Willi syndrome: In a recent placebo-controlled GH crossover trial, it was shown that in GH-treated young adults with PWS who had attained adult height, fat mass increased during placebo treatment, whereas fat mass decreased and lean body mass increased when resuming GH treatment (32).